Humana Inc (HUM)
Official siteHEALTHCARE • HEALTHCARE PLANS • NYSE
Market Cap: $54.05B
Last updated: Nov 17, 2026 at 11:06 AM ET
Humana Inc (HUM) Financials: Revenue, Profit and Cash Flow
Humana reported revenue of $129.66B for the fiscal year ended Dec 31, 2025, up 10.1% from the year before. That year, net income was $1.20B with a net margin of 0.9%, operating cash flow was $921.00M and free cash flow was $375.00M. The quarter ended Sep 30, 2026 had revenue of $41.16B and net income of $161.00M.
Revenue and Margins
The operating margin was 2.1% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $54.38B, a compound annual rate of 10.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $129.66B | +10.1% | 14.5% | 2.1% | 0.9% |
| Dec 2024 | $117.76B | +10.7% | 14.5% | 2.2% | 1.0% |
| Dec 2023 | $106.37B | +14.5% | 16.9% | 3.8% | 2.3% |
| Dec 2022 | $92.87B | +11.8% | 18.5% | 4.1% | 3.0% |
| Dec 2021 | $83.06B | +7.7% | 16.7% | 3.8% | 3.5% |
| Dec 2020 | $77.16B | +18.9% | 20.1% | 6.5% | 4.4% |
| Dec 2019 | $64.89B | +14.0% | 17.0% | 4.9% | 4.2% |
| Dec 2018 | $56.91B | +5.8% | 19.4% | 5.4% | 3.0% |
| Dec 2017 | $53.77B | -1.1% | 19.1% | 7.9% | 4.6% |
| Dec 2016 | $54.38B | N/A | 17.2% | 3.2% | 1.1% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 0.8% from the year before. In the quarter ended Sep 2026, net income fell 17.0% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B |
| Cost of revenue | $110.81B | $100.66B | $88.39B | $75.69B | $69.20B | $61.63B | $53.86B | $45.88B | $43.50B | $45.01B |
| Gross profit | $18.85B | $17.10B | $17.98B | $17.18B | $13.87B | $15.53B | $11.03B | $11.03B | $10.27B | $9.37B |
| Operating income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B |
| Net income | $1.20B | $1.21B | $2.48B | $2.80B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614.00M |
| EBITDA | $3.01B | $3.35B | $4.79B | $4.81B | $4.39B | $5.50B | $4.27B | N/A | $4.75B | $2.21B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.16B | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B |
| Gross profit | $4.83B | $5.50B | $5.94B | $3.79B | $4.66B | $4.82B | $5.58B | $3.83B | $4.28B | $4.50B | $4.49B | $3.68B |
| Operating income | $75.00M | $1.36B | $1.75B | -$808.00M | $400.00M | $1.10B | $2.01B | -$543.00M | $728.00M | $1.14B | $1.24B | -$348.00M |
| Net income | $161.00M | $693.00M | $1.18B | -$776.00M | $194.00M | $543.00M | $1.24B | -$683.00M | $480.00M | $678.00M | $739.00M | -$540.00M |
Balance Sheet
As of Dec 2025, total debt of $12.37B exceeded cash and equivalents by $8.17B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B |
| Current assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B |
| Cash and equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B |
| Total liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B |
| Short-term debt | $0 | $577.00M | $1.44B | $2.09B | $1.95B | $600.00M | $699.00M | $1.69B | $291.00M | $512.00M |
| Long-term debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $4.38B | $4.77B | $3.79B |
| Shareholder equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $57.28B | $57.20B | $55.28B | $48.75B | $49.72B | $50.36B | $50.93B | $46.31B | $50.01B | $50.09B | $50.09B | $46.89B |
| Total liabilities | $38.40B | $37.92B | $36.63B | $31.01B | $31.14B | $32.06B | $33.11B | $29.87B | $32.38B | $33.37B | $33.91B | $30.57B |
| Cash and equivalents | $6.93B | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | $4.69B |
| Shareholder equity | $18.82B | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | $16.26B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 40.7% of operating cash flow. Dividends and share repurchases together came to 154.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $921.00M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B |
| Capital expenditures | $546.00M | $575.00M | $1.00B | $1.14B | $1.34B | $964.00M | $736.00M | $612.00M | $524.00M | $527.00M |
| Free cash flow | $375.00M | $2.39B | $2.98B | $3.45B | $920.00M | $4.67B | $4.55B | $1.56B | $3.53B | $1.41B |
| Dividends paid | $430.00M | $431.00M | $431.00M | $392.00M | $354.00M | $323.00M | $291.00M | $265.00M | $220.00M | $177.00M |
| Share repurchases | $151.00M | $817.00M | $1.57B | $2.10B | $79.00M | $1.82B | $1.07B | $1.09B | $3.37B | $104.00M |
| Investing cash flow | $2.27B | -$2.95B | -$3.49B | -$1.01B | -$6.56B | -$3.06B | -$1.28B | -$3.09B | -$2.94B | -$1.36B |
| Financing cash flow | -$1.22B | -$2.49B | -$856.00M | -$1.91B | $3.02B | -$1.96B | -$2.29B | -$785.00M | -$945.00M | $732.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.16B | $1.97B | $1.25B | -$1.65B | $971.00M | $1.27B | $331.00M | -$528.00M | $1.86B | $1.21B | $423.00M | -$7.13B |
| Capital expenditures | $137.00M | $132.00M | $121.00M | $202.00M | $135.00M | $114.00M | $95.00M | $154.00M | $130.00M | $114.00M | $177.00M | $283.00M |
| Free cash flow | $2.03B | $1.83B | $1.13B | -$1.85B | $836.00M | $1.16B | $236.00M | -$682.00M | $1.73B | $1.10B | $246.00M | -$7.42B |
Frequently Asked Questions About HUM
What is Humana's annual revenue?
Humana reported revenue of $129.66B for the fiscal year ended Dec 31, 2025.
How fast is Humana's revenue growing?
Revenue was up 10.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 11.8%.
Is Humana profitable?
Yes. Humana reported net income of $1.20B for the fiscal year ended Dec 31, 2025, with a net margin of 0.9%.
How much free cash flow does HUM generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $921.00M minus capital expenditures of $546.00M produced free cash flow of $375.00M.
How much debt does Humana have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $12.37B, short-term debt of $0 and cash and equivalents of $4.20B.
HUM pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors